AstraZeneca – Investors in the Anglo-Swedish drugmaker should not yet worry about the failure of research. This is all part of the business model of a pure-play pharmaceutical company.
Repsol / Sacyr – Spanish oil company buys 10 per cent stake in itself to rescue its biggest shareholder from a debt default.
No comments:
Post a Comment